Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Dec 17, 2008

Premium
Celera has named Wayne Roe as a director of the company. Roe is a general partner for medical technology fund DFJ In-Cube Ventures. He also currently sits on the executive committee of the Maryland Angels Fund as well as the board of directors of ISTA Pharmaceuticals. Roe previously was chairman of Covance Health Economics and Outcomes Services.
 

 
Genomic Health said that it has appointed Ginger Graham to its board of directors. Graham is a former president and CEO of Amylin Pharmaceuticals. Prior to that role, she was group chairman in the office of the president, at Guidant. She also has held a number of management positions at Eli Lilly.
 

 
Anne Wojcicki, co-founder of 23andMe, has been named to the board of directors of the Foundation for the National Institutes of Health. She was one of five new directors announced last week. The others are Pfizer Chief Medical Officer Joseph Feczko; Peter Neupert, corporate vice president of the Health Solutions Group at Microsoft; Kurt Schmoke, dean of Howard University School of Law; and Samuel Thier, professor emeritus, medicine, and health care policy at Harvard Medical School and Massachusetts General Hospital.
 

 
Affymetrix said that Vernon Loucks will retire from its board of directors effective Jan. 1, 2009. His spot on the board will be filled by Affymetrix President and CEO Kevin King.
 
In addition, Affy disclosed in a filing with the US Securities and Exchange Commission that King will receive an increase in his annual base salary to $675,000 from $500,000. He also will be eligible for a target cash bonus of 75 percent of his annual salary.

Filed under

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.